This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ciccone, R.
Right arrow Articles by Colasanti, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ciccone, R.
Right arrow Articles by Colasanti, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2003, p. 2299-2302, Vol. 47, No. 7
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.7.2299-2302.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Inhibitory Effect of NO-Releasing Ciprofloxacin (NCX 976) on Mycobacterium tuberculosis Survival

R. Ciccone,1 F. Mariani,2 A. Cavone,1 T. Persichini,3 G. Venturini,3 E. Ongini,4 V. Colizzi,1 and M. Colasanti3*

Department of Biology, University of Rome "Tor Vergata,",1 Institute of Neurobiology and Molecular Medicine, National Council of Research,2 Department of Biology University of Rome "Roma Tre," Rome,3 Nicox Research Institute, Bresso, Milan, Italy4

Received 18 June 2002/ Returned for modification 29 July 2002/ Accepted 21 March 2003

Here, we report the antimycobacterial activity of NCX 976, a new molecule obtained adding a NO moiety to the fluoroquinolone ciprofloxacin, on Mycobacterium tuberculosis H37Rv strain, both in a cell-free model and in infected human macrophages. Unlike unaltered ciprofloxacin, NCX976 displayed a marked activity also at low-nanomolar concentrations.

* Corresponding author. Mailing address: Department of Biology, University "ROMA TRE," Viale Marconi, 446, I-00146 Rome, Italy. Phone: 39 06 55176342. Fax: 39 06 55176383. E-mail: colasant{at}uniroma3.it.

Antimicrobial Agents and Chemotherapy, July 2003, p. 2299-2302, Vol. 47, No. 7
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.7.2299-2302.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Timmins, G. S., Master, S., Rusnak, F., Deretic, V. (2004). Requirements for Nitric Oxide Generation from Isoniazid Activation In Vitro and Inhibition of Mycobacterial Respiration In Vivo. J. Bacteriol. 186: 5427-5431 [Abstract] [Full Text]  
  • Timmins, G. S., Master, S., Rusnak, F., Deretic, V. (2004). Nitric Oxide Generated from Isoniazid Activation by KatG: Source of Nitric Oxide and Activity against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48: 3006-3009 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»